MetaCap

HealthEquity Financial Ratios

NASDAQ: HQYConsumer DiscretionaryBusiness ServicesUSD

92.61-0.44 (-0.47%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

HealthEquity ratio analysis

HealthEquity earned a net margin of 16.4% in FY 2026, up from 8.1% a year earlier. Gross margin was 69.5% compared with a median of 59.6% over the prior 9 years. Return on equity reached 10.2%, meaning HealthEquity generated 0.10 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.45 versus 0.50 the year before, and the current ratio was 3.27. At the end of FY 2026, HQY traded at 34.8 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 34.8 to 696.3, with a median of 104.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

HealthEquity financial ratios (annual)

HealthEquity annual financial ratios
RatioFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
P/E ratio (at fiscal year end)34.83101.30120.83——696.25113.9054.3964.74107.57
Price / sales5.627.996.625.886.028.458.3213.7013.1015.55
Price / book3.504.543.252.672.464.504.308.258.6810.59
Gross margin69.5%64.8%62.3%57.1%56.1%56.6%61.3%63.1%58.8%59.6%
Operating margin24.6%13.5%11.8%1.1%-3.2%4.6%14.5%27.0%23.7%23.1%
Net margin16.4%8.1%5.6%-3.0%-5.9%1.2%7.5%25.7%20.6%14.8%
Free cash flow margin34.7%28.2%24.1%17.1%17.5%23.0%18.4%38.1%33.2%23.5%
Return on equity (ROE)10.2%4.6%2.7%-1.4%-2.4%0.6%3.8%15.5%13.7%10.1%
Return on assets (ROA)6.4%2.8%1.8%-0.8%-1.4%0.3%1.5%14.5%12.8%9.4%
Debt / equity0.450.500.430.490.500.721.180.00——
Current ratio3.273.064.762.922.292.251.9613.5812.9512.79
Revenue growth9.5%20.0%16.0%13.9%3.1%37.9%85.2%25.1%28.7%40.7%
EPS growth125.7%70.3%——-541.7%-79.3%-50.4%51.9%75.0%57.1%

Related